Off-market insider buying at Greenbrook TMS (GTMS)

Off-market insider buying at Greenbrook TMS (T:GTMS)

Updated Wednesday Jun 16, 2021 01:59 AM EDT
Greybrook Health Inc., a 10% Holder, acquired 200,000 Common Shares on a direct ownership basis at a price of US$10.000 through a prospectus or prospectus exempt offering on June 14th, 2021. This represents a $2,428,400 investment into the company's shares and an account share holdings change of 4.6%.

Greenbrook TMS is in the Healthcare Facilities & Services Sub Industry Group under the Healthcare Sector.

Greenbrook TMS Inc is a Canada-based company that offers transcranial magnetic stimulation (TMS) therapy. The TMS therapy is a non-invasive therapy for the treatment of major depressive disorder (MDD) and other mental health disorders. The TMS therapy provides local electromagnetic stimulation to specific brain regions known to be directly associated with mood regulation. It operates through approximately 124 Company-operated treatment centers.


Top